South Korea's acting President Choi Sang-mok on Wednesday said he hoped for a swift agreement within the country's parliament ...

CSL shares continued to slide after Tuesday's selloff, even as Morningstar hiked its valuation in the biopharmaceutical giant.

The Seoul government will hold an export strategy meeting next week to discuss measures aimed at minimizing the impact of the ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...

Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments.

We recently compiled a list of the 10 Mid-Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a look at where Nuvalent, Inc.

To boost its cardiovascular pipeline, Novartis has announced the acquisition of the company it co-founded with Blackstone ...

Travere Therapeutics shares rose sharply in early trading Tuesday after the biopharmaceutical company said it plans to seek expanded Food and Drug Administration approval of its kidney-disease drug ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

HC Wainwright reaffirmed their buy rating on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research ...